- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg med IDH mutation
I alt 1769 resultater
-
University of ChicagoRekrutteringMyeloproliferativ neoplasma | Blodkræft | IDH2-genmutation | IDH1 mutation | IDH mutationForenede Stater
-
Massachusetts General HospitalAgios Pharmaceuticals, Inc.AfsluttetIDH1 Mutation Myeloid NeoplasmaForenede Stater
-
AnHeart Therapeutics Inc.RekrutteringCholangiocarcinom med IDH1-mutation | Solide tumorer med IDH1-mutationKina
-
University Health Network, TorontoRekrutteringGliom | Solid tumor | Cholangiocarcinom | IDH mutationCanada
-
Istituto Clinico HumanitasCelgeneUkendtAkut myeloid leukæmi | IDH2-genmutation | IDH1-genmutationItalien
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); BeiGeneAfsluttetTilbagevendende glioblastom | Tilbagevendende WHO Grade III Gliom | Tilbagevendende WHO Grad II Gliom | IDH1 mutation | IDH2-mutationForenede Stater
-
Massachusetts General HospitalGlaxoSmithKlineRekrutteringTilbagevendende gliom | Gliom af lav kvalitet | Gliom, ondartet | IDH2-genmutation | IDH1 mutationForenede Stater
-
University Hospital Inselspital, BerneSwiss National Science FoundationRekrutteringGliom | Hjerne svulst | IDH mutationSchweiz
-
University of Texas Southwestern Medical CenterBayerTrukket tilbage
-
Stephen Bagley, MD, MSCEUniversity of Pennsylvania; Incyte CorporationRekrutteringGliom | Astrocytom | Oligodendrogliom | IDH mutationForenede Stater
-
Juan M Garcia-GomezHospital Universitario 12 de Octubre; Hospital Clínico Universitario de...RekrutteringGlioblastom | Glioblastoma Multiforme | Gliom af høj kvalitet | Astrocytom, grad IV | Glioblastom, IDH-mutant | Glioblastom, IDH-vildtype | Glioblastom IDH (Isocitrate Dehydrogenase) Vildtype | Glioblastoma IDH (Isocitrate Dehydrogenase) MutantSpanien
-
NRG OncologyNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeGliom | Oligoastrocytom | Anaplastisk astrocytom | Oligodendrogliom | Diffus astrocytom | WHO Grade III Gliom | IDH2-genmutation | IDH1-genmutation | 1p/19q SamsletningForenede Stater
-
Weill Medical College of Cornell UniversityBasser Research Center for BRCARekruttering
-
University of PennsylvaniaRekruttering
-
Azienda Ospedaliera Universitaria Policlinico Paolo...Ukendt
-
Jason J. Luke, MDBristol-Myers Squibb; Agios Pharmaceuticals, Inc.AfsluttetGliom | Avanceret solid tumor | IDH1 mutationForenede Stater
-
Memorial Sloan Kettering Cancer CenterUniversity of Pennsylvania; University of California, Los Angeles; Dana-Farber... og andre samarbejdspartnereAktiv, ikke rekrutterende
-
Pamela MunsterNational Cancer Institute (NCI)RekrutteringBRCA1 mutation | BRCA2 mutation | PALB2-genmutation | ATM-genmutation | BRCA mutation | Checkpoint Kinase 2 genmutationForenede Stater
-
Rigel PharmaceuticalsNationwide Children's HospitalIkke rekrutterer endnuAstrocytom | Gliom af høj kvalitet | Oligodendrogliom | Diffus Intrinsic Pontine Gliom | Diffus Midline Glioma, H3 K27M-Mutant | WHO Grade III Gliom | Metastatisk hjernetumor | Spinal Tumor | Astrocytom, grad III | Astrocytom, grad IV | IDH1 mutation | WHO Grad IV Gliom | Thalamus tumor | IDH1 R132 | IDH1 R132C | IDH1 R132H | IDH1... og andre forholdForenede Stater, Australien, Det Forenede Kongerige, Canada, Tyskland, Holland
-
University of California, San FranciscoGlaxoSmithKlineRekrutteringMetastatisk fast tumor | BRCA1 mutation | BRCA2 mutation | PALB2-genmutation | ATM-genmutationForenede Stater
-
European Institute of OncologyAfsluttetBRCA1 mutation | BRCA2 mutation | Psykosociale faktorerItalien
-
The University of Hong KongRekrutteringTilbagevendende glioblastom | Tilbagevendende gliom | Poly ADP Ribose Polymerase (PARP) hæmmer | PTEN-geninaktivering | IDH mutationHong Kong
-
nVision MedicalAfsluttetBRCA1 mutation | BRCA2 mutation | Atypi mistænkelig for malignitetForenede Stater
-
University of UtahAfsluttetPrimær myelofibrose | Anæmi | Trombocytopeni | Plasmacellemyelom | Tilbagevendende plasmacellemyelom | IDH2-genmutation | IDH1-genmutation | Sekundær myelofibrose | ASXL1 genmutation | EZH2-genmutationForenede Stater
-
Orbus Therapeutics, Inc.RekrutteringGlioblastom | Glioblastoma Multiforme | GBM | Glioblastom, IDH-vildtype | Glioblastom IDH (Isocitrate Dehydrogenase) VildtypeForenede Stater
-
Faeth TherapeuticsAktiv, ikke rekrutterendeAvanceret solid tumor | PIK3CA mutation | PTEN Tab af funktion MutationForenede Stater
-
University Hospital, MontpellierAfsluttet
-
Istituto Scientifico Romagnolo per lo Studio e...UkendtAML | FLT3-ITD mutation | FLT3-TKD mutationItalien
-
University Hospital, GhentFox Chase Cancer Center; Ziekenhuis Oost-LimburgAfsluttetBRCA1 mutation | BRCA2 mutation | hCGBelgien
-
Hillel Yaffe Medical CenterUkendt
-
Abramson Cancer Center at Penn MedicineRekruttering
-
Pasithea Therapeutics Corp.RekrutteringAvancerede solide tumorer | RAS-mutation | NF1 mutation | RAF mutationForenede Stater
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeAstrocytom, IDH-mutant, grad 2 | Astrocytom, IDH-mutant, grad 3Forenede Stater
-
Arog Pharmaceuticals, Inc.LedigFLT3-ITD mutation | FLT3/TKD-mutation | PDGFR-Alpha D842V | PDGFRA-genamplifikationItalien
-
University of California, San FranciscoBeiGene USA, Inc.; Pacific Pediatric Neuro-Oncology ConsortiumRekrutteringGlioblastom | Ondartet gliom | Tilbagevendende glioblastom | Tilbagevendende WHO Grade III Gliom | WHO Grade III Gliom | IDH2-genmutation | IDH1-genmutation | Gliom af lav grad | Tilbagevendende WHO Grad II Gliom | WHO Grade II GliomForenede Stater
-
National Cancer Institute (NCI)SuspenderetDiffus Gliom | Sekundær glioblastom | Glioblastom, IDH-vildtype | Astrocytom, IDH-mutant, grad 4Forenede Stater, Puerto Rico
-
Case Comprehensive Cancer CenterNational Institutes of Health (NIH); National Institute of Environmental...Ikke rekrutterer endnu
-
Pathway GenomicsAfsluttetNeoplasmer | MutationForenede Stater
-
Servier Bio-Innovation LLCInstitut de Recherches Internationales ServierIkke rekrutterer endnuLokalt avanceret eller metastatisk konventionelt chondrosarkom med en IDH1-mutation, ubehandlet eller tidligere behandlet med 1 systemisk behandlingsregime
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Istituto Oncologico di BariAfsluttetBrystkræft | BRCA1 mutation | BRCA2 mutation | KostændringerItalien
-
Federation Francophone de Cancerologie DigestiveRekrutteringTumorer | POLD1 genmutation | POLE Exonuclease Domain MutationFrankrig
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers Squibb; Vanderbilt University; Avon Breast Health Access FundAktiv, ikke rekrutterendeMetastatisk fast tumor | SF3B1 genmutation | Spliceosom mutation | U2AF1 genmutation | SRSF2-genmutationForenede Stater
-
Weill Medical College of Cornell UniversityAfsluttetBrystkræft | Gynækologisk kræft | BRCA1 mutation | BRCA2 mutationForenede Stater
-
Sun Yat-sen UniversityRekrutteringIkke-småcellet lungekræft (NSCLC) | EGFR-TKI resistent mutation | EGFR-TKI Sensibiliserende mutation | Somatisk mutation | KimlinjemutationerKina
-
University of PennsylvaniaInovio PharmaceuticalsRekruttering
-
Boehringer IngelheimAfsluttet
-
Thai Red Cross AIDS Research CentreChulalongkorn University; Queen Savang Vadhana Memorial Hospital, ThailandAfsluttetNVP Plasma niveau | NVP-relateret mutation | 3TC-relateret mutationThailand
-
University Health Network, TorontoAbbVie; CelgeneAfsluttetAkut myeloid leukæmi | Tilbagefaldende kræft | Ildfast kræft | IDH2-genmutationCanada
-
Boehringer IngelheimAktiv, ikke rekrutterendeSolide tumorer, KRAS-mutationSpanien, Det Forenede Kongerige, Forenede Stater, Belgien
-
Universitaire Ziekenhuizen KU LeuvenAfsluttetFamilieundersøgelse HbA2 Leuven-mutation.Belgien